Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McMaster University

$120,000.00

The effect of short-term oral ketone monoester supplementation on cerebral blood flow and brain network connectivity in adults with subjective cognitive decline

EF 2025-26

Résumé
Current treatments for dementia are mostly focused on improving symptoms when damage to brain health is often irreversible. This approach leaves a critical gap in available treatments for reducing dementia risk in aging and at-risk populations. Therefore, there is a need to develop strategies which target early impairments in brain health occurring with aging before progression to dementia. Impairments to brain blood flow and brain cell connections are some of the earliest age-related shifts in brain health that are heavily involved in the development of dementia. Additionally, women have a higher risk of developing dementia compared to men, which may be partially explained by different trajectories in these early changes in brain health occurring with aging. Commercially available oral ketone supplements represent a promising strategy to target these aging-related deficits in brain health and reduce dementia risk. However, there are limited high-quality research trials examining the effect of ketone supplementation on brain health in older adults with elevated dementia risk. Individuals with subjective cognitive decline (SCD) are 6 times more likely to develop dementia than age-matched adults and are considered the first clinical 'warning sign' of possible progression to dementia. This study will investigate the effects of short-term (14 days) ketone supplementation on brain blood flow and brain cell connections in older adults with SCD. We will also assess whether responses in these outcomes differ between males and females. This trial is necessary to evaluate the utility of ketone supplementation as an early lifestyle-based intervention for protecting crucial components of brain health with aging and in populations with high dementia risk. These results may have important implications for informing how we can effectively prevent and/or delay dementia development, to ultimately improve the health and quality of life of Canadians as they age.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
559320
Name
Rourke Aedan J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
The effect of short-term oral ketone monoester supplementation on cerebral blood flow and brain network connectivity in adults with subjective cognitive decline
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Brain Network Connectivity; Cerebral Blood Flow; Circulating Neurotrophins; Cognitive Function; Magnetic Resonance Imaging; Sex-Based Differences; Subjective Cognitive Decline
Abstract
Current treatments for dementia are mostly focused on improving symptoms when damage to brain health is often irreversible. This approach leaves a critical gap in available treatments for reducing dementia risk in aging and at-risk populations. Therefore, there is a need to develop strategies which target early impairments in brain health occurring with aging before progression to dementia. Impairments to brain blood flow and brain cell connections are some of the earliest age-related shifts in brain health that are heavily involved in the development of dementia. Additionally, women have a higher risk of developing dementia compared to men, which may be partially explained by different trajectories in these early changes in brain health occurring with aging. Commercially available oral ketone supplements represent a promising strategy to target these aging-related deficits in brain health and reduce dementia risk. However, there are limited high-quality research trials examining the effect of ketone supplementation on brain health in older adults with elevated dementia risk. Individuals with subjective cognitive decline (SCD) are 6 times more likely to develop dementia than age-matched adults and are considered the first clinical 'warning sign' of possible progression to dementia. This study will investigate the effects of short-term (14 days) ketone supplementation on brain blood flow and brain cell connections in older adults with SCD. We will also assess whether responses in these outcomes differ between males and females. This trial is necessary to evaluate the utility of ketone supplementation as an early lifestyle-based intervention for protecting crucial components of brain health with aging and in populations with high dementia risk. These results may have important implications for informing how we can effectively prevent and/or delay dementia development, to ultimately improve the health and quality of life of Canadians as they age.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rourke, Aedan J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~